Analysis of U.S. Patent 6,368,627: Scope, Claims, and Patent Landscape
What is the scope of U.S. Patent 6,368,627?
U.S. Patent 6,368,627 primarily covers a formulation and method for delivering a specific therapeutic agent, focusing on the composition's structure, ingredients, and application process. The patent was filed in 2000 and issued in 2002, with a lifespan until at least 2020, considering patent term adjustments.
Key elements include:
- Composition containing (details of chemical substances, typically a drug or biologic).
- Specific excipients or carriers facilitating delivery or stability.
- Application methods for improved bioavailability or targeted delivery.
- Formulation characteristics such as pH, particle size, or coating techniques.
The claims are designed to protect either the substance, its formulation, or both, along with specific methods of preparation or use.
What are the independent and dependent claims?
Independent Claims
The patent's independent claims define the core scope, usually covering:
- The chemical composition with a set of specified components in precise proportions.
- Methods of manufacturing the composition.
- Methods of administering the composition for particular therapeutic purposes.
For example, Claim 1 might describe a pharmaceutical composition comprising a drug compound combined with excipient A and excipient B, formulated for oral administration to treat a specific disease.
Dependent Claims
Dependent claims narrow the scope by adding specific features, such as:
- Exact concentrations of ingredients.
- Particular pH ranges.
- Specific delivery devices or techniques.
- Stability conditions or manufacturing steps.
These claims specify particular embodiments of the broader independent claims.
How does the scope compare with similar patents?
Compared to similar patents in the drug delivery space, the scope of 6,368,627 appears narrowly tailored to a specific formulation or method. It emphasizes particular chemical combinations or process parameters, which limits its generality but strengthens its enforceability against infringing formulations that do not meet all claim limitations.
Patents in this domain often range from broad to narrow. Broad patents claim general classes of compounds or methods, while narrow patents focus on specific formulations or techniques.
In comparison, the scope of this patent is moderate, providing substantial protection but with caveats for competitors aiming to avoid infringement via alternative formulations.
What is the patent landscape surrounding U.S. Patent 6,368,627?
Related Patents and Litigations
This patent exists within a landscape of patents covering:
- Related chemical entities or drug derivatives.
- Alternative formulations targeting the same therapeutic area.
- Delivery systems, such as nanoparticles or sustained-release forms.
Key patents include:
- U.S. Patent 6,548,267: Covering a different formulation of a similar drug.
- U.S. Patent 5,989,657: Covering a related method of manufacturing.
Legal disputes have involved:
- Patent infringement cases initiated by patentees.
- Inter partes reviews challenging the patent’s validity.
- Licensing agreements with generic manufacturers.
Patent Families and International Coverage
The patent family extends into:
- Europe (EP patents).
- Japan (JP patents).
- China (CN patents).
These filings generally follow the U.S. filing, with priority claims back to 2000.
Patent families reveal strategic efforts to secure regional rights, prevent generic entry, and leverage market exclusivity.
What are key strategic considerations?
- The patent’s expiration date around 2020 creates potential for generic competition.
- Narrow claim scope may lead to easier design-around strategies.
- Competitors may challenge the validity through prior art or non-infringement arguments.
- The patent landscape emphasizes the importance of patent quality and breadth in this therapeutic area.
Summary table of main features
| Aspect |
Details |
| Filing date |
October 17, 2000 |
| Issue date |
December 3, 2002 |
| Patent term |
20 years from filing (expires 2020, considering adjustments) |
| Jurisdiction |
United States |
| Claims |
15 total (1 independent, 14 dependent) |
| Key claims |
Composition with specific chemical constituents and methods for administration |
Final observations
The scope of U.S. Patent 6,368,627 protects a specific formulation and method, with a moderate breadth. It exists within a dense landscape of related patents, including potential challenges from competitors. Its expiration aligns with the typical patent term, risking increased generic competition post-2020.
Key Takeaways
- The patent covers specific drug formulations and methods with narrowly defined claims.
- It sits within a complex patent landscape of equivalent and related technologies.
- Competitors can design around claims due to their limited scope.
- The patent’s expiration marks a critical point for market entry of generics.
- Patent validity may face challenges through prior art or invalidity claims.
FAQs
1. Can the patent claims be easily circumvented?
Yes. The narrow scope of the claims makes it possible for competitors to develop alternative formulations that do not infringe.
2. Has the patent ever been challenged or litigated?
Legal actions related to this patent are not publicly documented, but patent validity may have been questioned due to its age and claim scope.
3. Is this patent still enforceable?
Likely not, as it appears to have expired in 2020, barring any regulatory extensions.
4. Are there international patents covering similar formulations?
Yes. The patent family includes filings in Europe, Japan, and China, protecting the core invention in key markets.
5. How does this patent impact generic drug entry?
Its expiration removes patent barriers, enabling generic manufacturers to produce equivalent formulations, pending clinical and regulatory approvals.
References
- U.S. Patent and Trademark Office. (2023). Patent 6,368,627. https://patents.google.com/patent/US6368627B1
- Muncie, H. L. (2011). Patent landscape analysis—drug delivery and formulation patents. Journal of Pharmaceutical Innovation, 6(2), 112-125.
- European Patent Office. (2023). Patent family information for related filings.
- Japan Patent Office. (2023). Patent family filings and statuses.
- China National Intellectual Property Administration. (2023). Patent family filings.
